(Q24244957)

1

0 references

Cláudia C Espírito-Santo

2

0 references

Ana A Borges

3

0 references

Joaquim Ferreira

4

0 references

Miguel M Coelho

5

0 references

Peter Moore

Cochrane Database of Systematic Reviews

6

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Botulinum toxin treatment in spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

A double blind trial of botulinum toxin "A" in torticollis, with one year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Statistics notes. Interaction 1: Heterogeneity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Idiopathic cervical dystonia: clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Experimental spasmodic torticollis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Cervical dystonia: clinical findings and associated movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Epidemiology of focal and generalized dystonia in Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

Natural history of adult-onset idiopathic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-contr

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021

Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003633.PUB2

7 January 2021